Varsha V Nair: h-index, Total Citations, and Citation Map
Varsha V Nair's h-index is 3 (2 i10-index, 96+ total citations across 11+ publications) according to Google Scholar as of May 2026. Varsha V Nair is affiliated with Amgen.
Varsha V Nair is a researcher affiliated with Amgen, specializing in Pulmonary delivery, Formulation development, Protein Therapeutics. Their work has been cited 96 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Varsha V Nair's Citation Metrics
Bibliometric impact based on 11 indexed publications.
- H-Index
- 3
- i10-Index
- 2
- Total Citations
- 96
- Citing Countries
- 34
As of May 2026.
Varsha V Nair has an h-index of 3 and 96 total citations across 11 publications, with research cited by institutions in 34 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Varsha V Nair's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles–an update
202374
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
3 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher advanced buccal drug delivery systems by synthesizing current knowledge on mucoadhesive polymers, films, and nanoparticles for small molecules and biologics.
The researcher developed an inhalable, excipient-free dry powder formulation of tigecycline to enable targeted treatment of pulmonary infections.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
